Financhill
Back

Sage Therapeutics Stock Price Chart

AI Is Disrupting Marketing - Invest in the Shift

Invest Now & Be Part of RAD Intel's Breakout Year
Sell
35

SAGE
Sage Therapeutics

Last Price:
$7.69
Seasonality Move:
1.71%

7 Day Trial

ALL ACCESS PASS

$ 7

Your Data Made Them Billions-Now It's Your Turn to Profit

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SAGE is experiencing buying pressure, which is a positive indicator for future bullish movement.

Sage Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 7.38 Buy
20-day SMA: 7.27 Buy
50-day SMA: 6.88 Buy
200-day SMA: 8.03 Sell
8-day EMA: 7.4 Sell
20-day EMA: 7.28 Buy
50-day EMA: 6.98 Buy
200-day EMA: 9.34 Sell

Sage Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.14 Buy
Relative Strength Index (14 RSI): 55.61 Buy
Chaikin Money Flow: 1603524 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.14 - 7.4) Buy
Bollinger Bands (100): (5.55 - 7.41) Buy

Sage Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Sage Therapeutics Stock

Is Sage Therapeutics Stock a Buy?

  • Sage Therapeutics share price is 7.40 while SAGE 8-day simple moving average is 7.38, which is a Buy signal.
  • The stock price of SAGE is 7.40 while Sage Therapeutics 20-day SMA is 7.27, which makes it a Buy.
  • Sage Therapeutics 50-day simple moving average is 6.88 while SAGE share price is 7.40, making it a Buy technically.
  • SAGE stock price is 7.40 and Sage Therapeutics 200-day simple moving average is 8.03, creating a Sell signal.

SAGE Technical Analysis vs Fundamental Analysis

Sell
35
Sage Therapeutics (SAGE) is a Sell

Is Sage Therapeutics a Buy or a Sell?

  • Sage Therapeutics stock is rated a Sell
    The current Sage Therapeutics [SAGE] share price is $7.40. The Score for SAGE is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.

Sage Therapeutics Stock Info

Market Cap:
455M
Price in USD:
7.40
Share Volume:
1.8M

Sage Therapeutics 52-Week Range

52-Week High:
21.22
52-Week Low:
4.62
Sell
35
Sage Therapeutics (SAGE) is a Sell

Sage Therapeutics Share Price Forecast

Is Sage Therapeutics Stock a Buy?

  • Sage Therapeutics share price is 7.40 while SAGE 8-day exponential moving average is 7.40, which is a Sell signal.
  • The stock price of SAGE is 7.40 while Sage Therapeutics 20-day EMA is 7.28, which makes it a Buy.
  • Sage Therapeutics 50-day exponential moving average is 6.98 while SAGE share price is 7.40, making it a Buy technically.
  • SAGE stock price is 7.40 and Sage Therapeutics 200-day simple moving average is 9.34, creating a Sell signal.

Fundamental Analysis of Sage Therapeutics

Is Sage Therapeutics a good investment?

  • Analysts estimate an earnings increase this quarter of $0.71 per share, an increase next quarter of $0.42 per share, an increase this year of $2.66 per share, and an increase next year of $1.19 per share.

Technical Analysis of Sage Therapeutics

Should I short Sage Therapeutics stock?

* Sage Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.